INTRODUCTION {#SEC1}
============

IS200 is the smallest prokaryotic transposon and is widely conserved in Enterobacteriaceae and found throughout Eubacteria and Archaea. One unusual feature of IS200 elements is the high copy number achieved in *Yersinia* and *Salmonella* spp. ([@B1]--[@B3]). Many strains of *Yersinia pestis* contain more than 50 copies of the IS200 ortholog IS1541, while strains of *Salmonella enterica* subsp. *enterica* serovar Typhimurium (*S*. Typhimurium) typically contain 5--12 copies and *S. Typhi* contains 26 copies of IS200 per genome. In the above cases, all IS200 paralogs appear to be 100% conserved and in general IS200 orthologs share \>90% identity. A highly active transposon might be expected to achieve this high copy number and repeated transposition would maintain sequence identity of paralogs; however, IS200 is an essentially dormant transposon ([@B1],[@B2]). Conservation and copy number might therefore reflect a selective pressure on the host bacterium to maintain IS200. Transposons can contribute to host fitness in several ways including: (i) by mediating DNA rearrangements that influence host gene expression and gene structure ([@B4]); (ii) contributing passenger genes such as antibiotic resistance determinants ([@B5]); (iii) providing a rich source of DNA regulatory sequence ([@B6]); (iv) providing proteins and/or protein motifs from transposase proteins that can be domesticated by the host ([@B7]); and (v) providing regulatory RNAs that affect host gene expression ([@B8],[@B9]). As a simple insertion sequence, IS200 does not encode any passenger genes, and the dormancy of IS200 suggests that this element would not contribute transposition-dependent functions to the host.

Non-coding RNAs (ncRNA) play a crucial role in regulating many critical processes in bacteria including outer membrane homeostasis, metabolism and virulence ([@B10],[@B11]). The largest class of bacterial ncRNA are small RNAs (sRNA) that base-pair with target mRNAs and affect translation and/or transcript stability. sRNAs are typically expressed from intergenic regions and therefore have limited sequence complementarity with their trans-encoded targets. A related class of ncRNA are antisense RNAs (asRNA) which are encoded on the opposite strand of DNA to their target mRNA. Accordingly, asRNAs have much more extensive complementarity with their cis-encoded targets. Note that both sRNAs and asRNAs act by an antisense mechanism, but are classified based on their genomic context relative to target mRNAs. The third and smallest class of bacterial ncRNAs act by binding to and regulating protein activity (e.g. 6S RNA, CsrB/C). The classic distinction between these three classes of ncRNA has been challenged with continually emerging examples of dual-function ncRNA, including sRNAs derived from mRNAs ([@B12]--[@B15]), base-pairing sRNAs acting to modulate protein activity ([@B16]--[@B19]) and asRNAs acting in trans to regulate genes expressed from different loci ([@B20],[@B21]). One common feature for base-pairing ncRNAs is that the RNA-binding protein Hfq is typically required to facilitate pairing when there is limited complementarity between an sRNA and mRNA ([@B22]). In general, an interaction between Hfq and an mRNA or sRNA indicates that the RNA is involved in post-transcriptional regulation via a base-pairing mechanism.

IS200 elements express two RNA molecules (Figure [1A](#F1){ref-type="fig"}), the first is an mRNA encoding the transposase protein (*tnpA*), and the second is an asRNA (art200, previously named STnc490) that is complementary to the *tnpA* 5΄UTR ([@B1],[@B23],[@B24]). Expression of the IS200 TnpA is strongly repressed by four independent mechanisms. First, the left-end of IS200 contains an inverted repeat that forms a strong, bi-directional, Rho-independent transcriptional terminator. This regulatory element ensures that impinging transcription does not activate *tnpA* expression and terminates ∼85% of upstream transcripts ([@B23]). Second, translation of *tnpA* is strongly repressed by mRNA secondary structure that includes the Shine-Dalgarno sequence (SD) (Figure [1B](#F1){ref-type="fig"}). This stem-loop element represses *tnpA* expression 20-fold by preventing 30S ribosome binding. Third, art200 base-pairs with *tnpA* to inhibit ribosome binding, and reduces translation 15-fold. Lastly, *tnpA* translation is inhibited directly by the RNA-binding protein Hfq, which recognizes a sequence immediately upstream of the SD and accordingly stericly occludes ribosome binding. The three post-transcriptional mechanisms act independently and together supress translation of *tnpA* by at least 750-fold, ensuring almost no TnpA protein is produced ([@B1]). While these regulatory mechanisms appear to be redundant, *tnpA* expression is reasonably high in *S*. Typhimurium for a transposon (∼10% the expression of *hfq* in mid-exponential phase ([@B25])). It therefore appears that IS200 elements have evolved to maintain moderate transcription of *tnpA* from an IS200 encoded promoter, but close to no synthesis of TnpA. Another noteworthy feature of IS200-encoded RNAs is that art200 expression appears to be growth phase regulated, with increased expression when *S*. Typhimurium transitions to stationary phase in rich media, as well as in growth media that stimulate *Salmonella* pathogenicity island (SPI) expression ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}; ([@B24])). Additionally, art200 interacts with Hfq *in vivo*, although Hfq is dispensable for antisense regulation of *tnpA* expression. Intriguingly, while art200 expression is increased in stationary-phase, *tnpA* expression decreases ∼5-fold ([@B25]), which may indicate that art200 expression is altered to control *tnpA* RNA levels. One explanation for the unusual characteristics of IS200-encoded RNAs is that a moderately expressed but never translated *tnpA* provides a way in which IS200 transposition could be rapidly activated under certain conditions. However, previous work found that IS200 transposition is remarkably rare, even when post-transcriptional regulation is completely eliminated ([@B1]). With respect to art200\'s expression patterns and Hfq-binding properties, this could simply reflect stochastic evolution of the promoter and sequence of a regulatory RNA. A more intriguing explanation for the peculiar properties of *tnpA* and art200 is that one or both IS200-encoded RNAs serves a regulatory role independent of controlling transposition. In this scenario, an IS200 encoded RNA might provide a selective advantage to *Salmonella* spp. and accordingly explain the conservation and high copy number of this transposon.

![IS200 and experimental approach. (**A**) IS200 encodes a transposase mRNA (*tnpA*, red) and an antisense RNA (art200, blue). The *tnpA*~trunc~-255 transcript encodes the first 255 nt of *tnpA* fused to the last 108 nt of SgrS (black, includes an intrinsic terminator) and is expressed from the Tet promoter. (**B**) Approach used to deplete art200. Pairing between *tnpA* (red) and art200 (blue) results in degradation of art200. The M1 mutation alters three critical nucleotides in the terminal loop of *tnpA* and prevents pairing with art200. The sequestered Shine-Dalgarno sequence (SD) of *tnpA* is indicated with a box and the translation start codon (AUG) is shown. (**C**) Heat map showing expected expression of IS200 RNAs in *Salmonella* Typhimurium LT2 containing plasmids over-expressing either wild-type (WT) or M1 forms of *tnpA*~trunc~-255. Note that '*tnpA*' signifies endogenous transposase transcript and 'vector' is a control plasmid that does not encode *tnpA*.](gkx094fig1){#F1}

In the current work we performed an RNA-Seq experiment to ask if IS200-encoded RNAs affect gene expression in *S*. Typhimurium. We provide evidence that the 5΄UTR of *tnpA* represses many genes including the SPI-1 encoded transcription factor, *invF*. Our data suggests that *tnpA* base-pairs with *invF*, and the consequence of this interaction is downregulation of the SPI-1 translocon (*sicAsipBC*) and SPI-1 mediated invasion. This work is the first demonstration of a bacterial transposon encoding regulatory RNAs that influence host gene expression.

MATERIALS AND METHODS {#SEC2}
=====================

Growth conditions, strains and plasmids {#SEC2-1}
---------------------------------------

Unless otherwise stated, *S*. Typhimurium was grown at 37°C with shaking in Lennox Broth (LB; 5 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract). For experiments where RNA was extracted at multiple time-points, overnight cultures were diluted once (1:100 into 7 or 25 ml) and aliquoted (2 ml) into separate culture tubes for each time point. For SPI-1 inducing conditions, cells were grown as previously described ([@B24]). For SPI-2 inducing conditions, cells were grown overnight in LB and diluted 1:100 into acidic low-phosphate, low-magnesium media (80 mM MES pH 5.8, 5 mM KCl, 7.5 mM (NH~4~)~2~SO~4~, 0.5 mM K~2~SO~4~, 38 mM glycerol, 0.1% casamino acids \[w/v\], 8 μM MgCl~2~, 337 μM KH~2~PO~4~) ([@B26]). Where appropriate, antibiotics were used at the following concentrations: tetracycline (tet), 15 μg/ml; chloramphenicol, 20 μg/ml; kanamycin (kan), 25 μg/ml; streptomycin (str), 150 μg/ml. For experiments with marked alleles, selection was only used in the overnight culture.

All strains and plasmids used in this study are listed in Table S4 and oligonucleotides are listed in Table S5. *S*. Typhimurium str. LT2 or SL1344 were considered wild-type (WT) strains, and derivative strains were made in the SL1344 background. *Escherichia coli* DH5α was used for routine cloning and plasmid propagation.

Mutant strains of SL1344 were constructed by Lambda Red recombineering ([@B27]) and all mutations were checked by colony Polymerase chain reaction (PCR). DBH401 (Δ*tnpA~2/4/6/7~*) and DBH415 (Δ*tnpA~1-7~*, referred to as *ΔtnpA*) were constructed by transducing individual IS200 knockout alleles into a single strain. DBH393 and related strains were created by inserting a *kan-pTet* (or *cm-pTet* for DBH398) cassette in front of *tnpA_7* such that the Tet promoter is driving transcription of *tnpA* (*tnpA_7::kan-pTet*). Complementation strains were constructed by transducing the *tnpA_7::kan-pTet* or *tnpA_7::kan-pTet(+19)* from DBH416 or DBH419 into the *ΔtnpA* (DBH415) background. Further details of strain and plasmid construction are provided in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}.

RNA isolation, northern blot and primer extension {#SEC2-2}
-------------------------------------------------

Total RNA was prepared by the hot acid phenol method ([@B28]). Northern blots were performed as previously described ([@B19]) using 5 or 10 μg of total RNA and 5΄^32^P-labeled oligonucleotide probes (oDH428 *tnpA;* oDH427, art200) or a uniformly ^32^P-labeled riboprobe (5S rRNA, generated with oDH234 and oDH235; art200, generated with oDH450 and oDH394). Primer extension was performed as previously described ([@B1]) using 9 μg of total RNA and primers oDH428 or oDH394 (*tnpA*) or oDH710 (*invF*). Processed RNA was eliminated by terminator exonuclease (TEX) (Epicentre) treatment according to the manufacturer\'s instructions.

RNA-seq and data analysis {#SEC2-3}
-------------------------

*Salmonella* Typhimurium LT2 was transformed with pDH900 (empty vector), pDH899 (pTet-*tnpA*~trunc~^WT^-255) or pDH914 (pTet-*tnpA*~trunc~^M1^-255). Two colonies from each transformation were each used to inoculate 1 ml of LB-Luria (0.5 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract) with tet and were grown for 8 h. Precultures were subcultured 1:100 into LB-Luria and grown for 16 h. Total RNA was isolated and treated with TURBO DNase (Ambion) to remove residual genomic DNA and submitted to the London Regional Genomic Centre for library preparation and sequencing. Libraries were prepared with the Ribo-Zero (Gram-Negative Bacteria) (Epicentre) and ScriptSeq v2 (Epicentre) kits. The six libraries (two biological replicates from each strain) were pooled and sequenced with 50 cycles on an Illumina MiSeq. Reads were aligned to the *S*. Typhimurium LT2 genome (NC_003197) with Rockhopper ([@B29]) (Table S1) and differential expression was analyzed using ALDEx2 ([@B30]). More detail on data analysis is provided in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}.

Reverse transcription quantitative polymerase chain reaction (RT-qPCR) {#SEC2-4}
----------------------------------------------------------------------

DNase treated RNA (2 μg) was converted to cDNA with the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems); cDNA was diluted to 30 ng/μl in TE (50 mM Tris--HCl, pH 8.0, 1 mM Ethylenediaminetetraaceticacid (EDTA)) and stored at −20°C. A minimum of three biological replicates were analyzed in technical triplicate in each experiment and the 16S rRNA (*rrsA*) was used as a reference gene for relative quantitation. Reactions (20 μl) contained 10 ng of cDNA, 500 nM of each primer ([Supplementary Table S5](#sup1){ref-type="supplementary-material"}) and PowerUP SYBR Green Master Mix (Applied Biosystems). Standard settings on the ViiA 7 Real-Time PCR System were used except for the anneal/extension step, which was performed at 60.5°C. Relative expression of each target was calculated by the efficiency corrected method ([@B31]). The amplification efficiency was determined for *tnpA* (2.20), *thrS* (2.04)*, rrsA* (2.00), *invF* (2.12), *sipB* (2.03), *sipC* (2.01) and *sicA* (2.00); an efficiency of 2.0 was used for all other primer pairs.

Western blot {#SEC2-5}
------------

DBH388 (*invF::3X-FLAG-kan*) transformed with pDH900 (empty vector), pDH960 (pTet-*tnpA*~trunc~-50) or pDH962 (pTet-*tnpA*~trunc~-200) was grown to OD~600~ = 0.5 and cells from 1 ml of culture was collected by centrifugation. For the experiment comparing DBH388 to DBH398 (*invF::3X-FLAG-kan tnpA_7::kan-pTet*), the volume of culture was adjusted so that an equivalent of 0.5 OD were harvested. The cell pellet was resuspended in 200 μl of sodium dodecyl sulphate (SDS) sample buffer (60 mM Tris--HCl, pH 6.8, 2% SDS \[w/v\], 0.01% bromophenol blue \[w/v\], 1% β-mercaptoethanol \[v/v\]) and boiled for 5 min. Samples (10 μl) were resolved on 10% polyacrylamide gels and electroblotted to a polyvinylidene difluoride (PVDF) membrane. Membranes were incubated in 5% milk overnight with primary antibody (1:5000 dilution: mouse α-FLAG M2, Sigma; rabbit α-GroES, Sigma; mouse α-DnaK, Enzo), followed by incubation with a 1:5000 dilution of secondary antibody (α-mouse-HRP or α-rabbit-HRP, Promega). Blots were developed with a Pierce ECL 2 western blotting substrate and a STORM scanner. Membranes were stripped and re-probed for loading controls (GroES/DnaK). Bands were quantitated in ImageQuant and the amount of InvF*-*3× FLAG was normalized to the internal standard (GroES/DnaK) and then the control strain (empty vector or DBH388).

Gentamicin protection (invasion) assay {#SEC2-6}
--------------------------------------

Invasion assays were performed essentially as previously described ([@B32]). Tissue-culture plates (24-well) were seeded with ∼0.05 × 10^6^ HeLa cells per well in 1 ml of Dulbecco\'s modified eagle\'s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 U/ml) and str (100 μg/ml) 20--22 h prior to the invasion assay. At the time of the assay cells were 60--70% confluent (∼0.1 × 10^6^ cells per well).

Freshly streaked colonies of DBH347 (SL1344 WT), DBH393 (SL1344 *tnpA_7::kan-pTet*), DBH415 (SL1344 *ΔtnpA*) or DBH418 (SL1344 Δ*invA*) were used to inoculate 2 ml of SPI-1 inducing media (17.5 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract) containing 150 μg/ml str and 25 μg/ml kan (for DBH393 and DBH418). Overnight cultures were subcultured 1:100 into LB and grown for 2 h or 3 h with shaking to mid- (OD~600~ = 0.5) or late-exponential phase (OD~600~ = 1.2). Bacterial cells were washed with Phosphate buffered saline (PBS) and diluted in DMEM/10% FBS to a concentration of 1 × 10^7^ cfu/ml.

HeLa cells were washed with PBS and 1 ml of bacterial suspension (MOI of 100) was added to two wells for each culture (technical duplicate). Serial dilutions of the bacterial suspension were plated on LB agar plates with 150 μg/μl str to determine the input number of bacteria.

Bacterial cells were centrifuged onto the HeLa monolayer at 500 × *g* for 3 min at room temperature and then incubated at 37°C for 10 min. Bacterial cells were washed away with PBS and 1 ml of fresh DMEM/10% FBS was added to each well, followed by a 20 min incubation at 37°C. Culture media was replaced with DMEM/10% FBS containing 100 μg/ml gentamicin followed by a 30 min incubation at 37°C to kill extracellular bacteria. After washing with PBS, HeLa cells were resuspended in 1 ml lysis solution (PBS, 5 mM EDTA, 0.5% Triton X-100, 0.1% SDS) and serial dilutions were plated on LB with 150 μg/ml str to determine the output bacterial cell counts. Invasion was calculated as the ratio of recovered cells to the input and normalized to the WT strain for each experiment.

Electrophoretic mobility shift assay (EMSA) and lead footprinting {#SEC2-7}
-----------------------------------------------------------------

*In vitro* pairing experiments were performed as previously described ([@B1],[@B33]) except that the RNAs were mixed prior to denaturation.

Growth curves {#SEC2-8}
-------------

Growth was measured in a Multiskan Go microplate spectrophotometer. Cells from two overnight cultures (biological replicates) of each strain (DBH347, WT; DBH415, Δ*tnpA*; DBH416, Δ*tnpA*/ *tnpA_7::kan-pTet*) were washed with sterile saline and diluted 100-fold into LB. Two hundred microliters of each dilution was added to three wells (technical replicates) of a 96-well microplate. Cultures were grown with continuous shaking at 37°C for 12 h and absorbance at 600 nm (A~600~) was measured every 15 min. Note that the A~600~ was not adjusted for path length and light scattering from the microplate lid and is therefore not directly comparable to optical density readings measured in a standard cuvette.

RESULTS {#SEC3}
=======

Profiling changes in *S*. Typhimurium gene expression in response to altered levels of IS200-encoded transcripts {#SEC3-1}
----------------------------------------------------------------------------------------------------------------

We used RNA-Seq to analyze gene expression in *S*. Typhimurium LT2 under conditions where levels of *tnpA* and art200 were altered from native levels. In one strain we introduced a plasmid that constitutively over-expresses a truncated form (nt 1--255) of the transposase mRNA (*tnpA*~trunc~^WT^-255, Figure [1A](#F1){ref-type="fig"}). This strain produces very low amounts of art200 because *tnpA*~trunc~^WT^-255 RNA pairs with art200 and this pairing promotes degradation of art200 (Figure [1B](#F1){ref-type="fig"} and [C](#F1){ref-type="fig"}; [Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). When we looked for differentially expressed genes in this strain versus an empty vector control strain, we identified 187 genes with altered expression (Figure [2A](#F2){ref-type="fig"}, black dots; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}), 99 of which had at least a 2-fold change in expression. This altered pattern of gene expression could arise from either depletion of art200 and/or the over-expression of the truncated *tnpA* mRNA. To distinguish between these possibilities, we profiled gene expression in a third strain expressing a truncated form of *tnpA* (*tnpA*~trunc~^M1^-255) that is unable to pair with art200 (Figure [2B](#F2){ref-type="fig"}). Genes affected by depletion of art200 would show differential expression when *tnpA*~trunc~^WT^-255 was over-expressed but not when *tnpA*~trunc~^M1^-255 was over-expressed. When all three comparisons were made, only six genes appeared to be uniquely regulated by art200 (Figure [2C](#F2){ref-type="fig"}; *glnH, gltI, acs, icdA, hutU* and a predicted asRNA to the 3΄end of *fadR*). In contrast, genes regulated by *tnpA*~trunc~ over-expression would show differential expression in both WT and M1 *tnpA*~trunc~ strains when compared to an empty vector. A total of 73 genes fit this criterion (Figure [2C](#F2){ref-type="fig"}). Based on this analysis we concluded that transcripts derived from IS200 impact on host gene expression and that high levels of a truncated form of *tnpA* that includes the 5΄UTR has a greater impact on host gene expression than depletion of art200.

![Summary of RNA-Seq data. (**A** and **B**) Expression plot comparing relative abundance (log~2~ clr) of *Salmonella Typhimurium* LT2 transcripts in the presence of an empty vector (x-axis) or plasmid expressing WT (y-axis, A) or M1 (y-axis, B) *tnpA*~trunc~-255. Differentially expressed genes (Effect size \>2) are indicated in black and dotted lines indicate a 2-fold change in expression from the line of best fit for the data (A, Pearson\'s *r* = 0.9393; B, Pearson\'s *r* = 0.9348). Reads derived from *tnpA*~trunc~-255 mapped to either the IS200 transposase coding sequence (*tnpA*) or 5΄UTR (*tnpA* 5΄UTR) and are indicated in blue. SPI-1 genes *sicA, sipB, sipC* and *invF* are highlighted in red; note that *invF* was repressed \>3-fold by *tnpA*~trunc~^WT^-255 but fell below our cut-off for differential expression (Effect size = −1.2025). Genes with an Effect size \<2 are indicated in grey and are not considered to be differentially expressed. (**C**) Venn diagram showing the overlap of genes identified as differentially expressed when comparing the empty vector to *tnpA*~trunc~^WT^-255 (blue) or *tnpA*~trunc~^M1^-255 (yellow) or *tnpA*~trunc~^WT^-255 to *tnpA*~trunc~^M1^-255 (green). (**D**) Results of GO Enrichment Analysis. The 187 genes identified as differentially expressed when comparing expression in the presence of the vector versus *tnpA*~trunc~^WT^-255 were used as a query gene list for GO Enrichment Analysis. The log~2~ fold change (Vector versus *tnpA*~trunc~^WT^-255) of genes in the three enriched biological processes are shown along with the enrichment score and *P*-value from the PANTHER Over-representation test. Horizontal bars indicate the median fold-change for each biological process.](gkx094fig2){#F2}

Lastly, we searched for cellular processes enriched with genes affected by *tnpA*~trunc~^WT^ over-expression. This analysis found that *tnpA* over-expression significantly represses genes involved in pathogenesis, glycerol-3-phosphate metabolism and oxidation--reduction reactions (Figure [2D](#F2){ref-type="fig"}). Similar results were obtained when pathway analysis was performed on the 73 genes affected by both WT and M1 *tnpA*~trunc~ constructs ([Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}). The strongest change in gene expression in any of these pathways was the SPI-1 encoded effector protein, SipC (10-fold repression by over-expression of *tnpA*~trunc~^WT^-255). As *S*. Typhimurium LT2 is avirulent ([@B34]), we switched to the virulent SL1344 strain (seven copies of IS200 versus six copies of IS200 in LT2) for subsequent studies.

Characterization of *tnpA* derived RNAs {#SEC3-2}
---------------------------------------

Our RNA-Seq analysis revealed that over-expression of the first third of transposase mRNA had a substantial impact on gene expression in *S*. Typhimurium. While this points to *tnpA* mRNA acting as a regulatory RNA, we thought it more likely that a naturally truncated or processed form of *tnpA* is produced from the 5΄end to act as a regulatory RNA. This would be in line with other recently discovered mRNA derived sRNAs ([@B35]). We initially looked for evidence of an sRNA derived from the 5΄end by performing a northern blot (5΄UTR probe) on RNA isolated from a strain expressing native levels of *tnpA* (WT) or a strain where *tnpA* was over-expressed through the fusion of the pTet promoter to one copy of *tnpA* in the chromosome. In the latter strain we detected three species, two of which are ∼90 and ∼110 nt and the other is \>310 nt (Figure [3A](#F3){ref-type="fig"}, lane 3). The 90 and \>310 nt species were also just detectable in the strain expressing *tnpA* at native levels (lane 1). In contrast, none of these species were detected in a strain where four of seven copies of the *tnpA* gene were deleted (lane 2). Additionally, both the 110- and 90-nt species were detected by northern blots on samples where *tnpA*~trunc~-255 was over-expressed (Figure [4A](#F4){ref-type="fig"}). Taken together these results show that: (i) the native *tnpA* gene generated one or more sRNAs; (ii) sRNA production does not require more than 255 bp of the *tnpA* gene; and (iii) sRNA production occurs independent of the promoter used to drive *tnpA* transcription. The latter point is suggestive of sRNAs being produced through RNA processing of the *tnpA* transcript.

![Processing of the *tnpA* transcript. (**A**) A northern blot of *tnpA* RNA isolated from SL1344 strains expressing *tnpA* at endogenous levels (WT), over-expressing *tnpA* from the *tnpA*\_*7* locus (*tnpA_7::kan-pTet*, pTet) or with a reduced number of endogenous copies of *tnpA* (*ΔtnpA~2/4/6/7~*, Δ*tnpA*). Full-length (closed circle) and processed (open circle) forms of *tnpA* were detected with a probe that anneals to the *tnpA* 5΄UTR (oDH429). 5S rRNA was used as a loading control. (**B** and **D**) 5΄ends of *tnpA* were mapped using primer extension. RNA was isolated from the above strains (two replicates) and *tnpA* was detected using a primer that anneals to the 5΄UTR (nt 46--64, B) or coding sequence (nt 151--171, D). ddNTP sequencing lanes (using *tnpA_7::kan-pTet* RNA as a template) were used to determine the nucleotide position of primer extension products relative to the transcription start site (+1, 'Full-length'). (**C**) *tnpA* is processed at U~17~ and A~19~. RNA isolated from the WT or *tnpA_7::kan-pTet* strains was treated with TEX (+) or incubated with buffer (−) before *tnpA* was detected by primer extension. (**E**) Summary of primer extension experiments. The major primer extension products from parts B and D are illustrated along with the primer binding sites. The two primers used for primer extension would detect different molecules of *tnpA* based on processing occurring between the primer binding sites. From the positions of 5΄ ends and the size of low molecular weight RNA species in the northern (part A), we infer that the *tnpA* transcript is processed at two sites to produce two stable 5΄ UTR-containing species (site B, *tnpA*-110; sites A+B, *tnpA*-90). (**F**) Proposed processing pathway for *tnpA*. Full-length *tnpA* would be processed at site 'B' (purple) generating *tnpA*-110. Subsequent processing at site 'A' on *tnpA* (red) generates *tnpA*-90, which is the most stable *tnpA* species. The binding site for the northern probe (oDH429) is indicated in green.](gkx094fig3){#F3}

![The 5΄end of *tnpA* represses *invF* mRNA and protein expression. (**A**) Northern blot of RNA isolated from cells expressing various *tnpA*~trunc~ constructs from a plasmid. The processed forms of *tnpA* were detected with an oligonucleotide probe that anneals to the 5΄UTR of *tnpA* (shown in Figure [3E](#F3){ref-type="fig"}). Note that the probe used for detecting *tnpA* anneals to sequence absent (*tnpA*~trunc~-50) or mutated (*tnpA*~trunc~^M1^-255) in certain constructs and accordingly only endogenous *tnpA* was detected. The membrane was stripped and reprobed first for art200 and then 5S rRNA as a loading control. (**B**) RT-qPCR was performed on *Salmonella* Typhimurium SL1344 cells expressing different truncated forms of *tnpA* grown to late-exponential phase (OD~600~ = 1.2). (**C**) InvF western blot on SL1344 cells expressing *tnpA*~trunc~ constructs. Cells contained a 3× FLAG tag integrated at the end of the *invF* gene and cell extracts (prepared at mid-exponential phase; OD~600~ = 0.8) were probed with an α-FLAG antibody. WT SL1344 cells provided a negative control, and GroES was used as a loading control. (**D**) RT-qPCR was performed on SL1344 strains expressing full-length *tnpA* from the native (WT) or Tet (*tnpA_7::kan-pTet*) promoter grown to late-exponential phase (OD~600~ = 1.2). (**E**) InvF western blot on SL1344 strains expressing full length *tnpA*. Extracts were prepared at an OD~600~ of 0.4 or 1.0 from cells expressing *tnpA* at endogenous levels (−) or constitutively over-expressed from the *tnpA_7::cm-pTet* locus (+). InvF was detected as in (B) and DnaK served as a loading control. (**F**) HeLa cells were infected with WT or *tnpA_7::kan-pTet* strains of *S*. Typhimurium SL1344 (MOI of 100) grown to late-exponential phase (OD~600~ ∼ 1.2). A non-invasive strain (Δ*invA*) was also assayed as a control. Bars represent the average invasion for seven biological replicates (measured in technical duplicate) from two independent experiments. In each experiment, the mean invasion of the WT strain (0.3 and 1.0% of input) was set to 100. In panels B--E, error bars show the standard error on the mean for four (B and D) or three (C and E) biological replicates.](gkx094fig4){#F4}

We next performed primer extension on the above RNA samples to map 5΄ends of each species. In one experiment we used a primer that anneals to the 5΄UTR (nt 46--64). The results show that the majority of *tnpA* transcripts start at position 19 rather than the expected transcription start site (Figure [3B](#F3){ref-type="fig"}). This pattern was observed both when *tnpA* was over-expressed and expressed at native levels. We also show that prior treatment of the RNA with 5΄monophosphate-dependent TEX resulted in loss of the primer extension signal at nt 19, indicating that this 5΄end is generated through transcript processing (Figure [3C](#F3){ref-type="fig"}). In a second experiment we used a primer that anneals in the coding sequence (nt 151--171) (Figure [3D](#F3){ref-type="fig"}). Here we also identified the position 19 5΄end and additional 5΄ends surrounding position 108. These alternative 5΄ends were also lost upon TEX treatment, indicating processing in a second region of the *tnpA* transcript ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). Processing events at positions 19 and 108 would generate a 5΄UTR containing species of ∼90 nt. In contrast, processing at only the downstream site would generate a 5΄UTR containing species of ∼110 nt in length. Based on these experiments, we infer that processing at sites designated A and B in Figure [3D](#F3){ref-type="fig"} generate stable *tnpA* encoded sRNAs (Figure [3E](#F3){ref-type="fig"} and [F](#F3){ref-type="fig"}).

Repression of SPI-1 encoded genes by *tnpA* {#SEC3-3}
-------------------------------------------

To test the hypothesis that one or both of the above described sRNAs are actually the active molecules for regulating host genes, we made additional *tnpA*~trunc~ constructs (first 50, 200 and 250 nt of *tnpA* over-expressed from plasmids, [Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}) to determine the minimal *tnpA* required for affecting gene expression in *S*. Typhimurium; both *tnpA*~trunc~−200 and −250 are processed to produce ∼110 and ∼90 nt species (Figure [4A](#F4){ref-type="fig"}). Note that *tnpA*~trunc~−50 is not detected by northern blot as this construct does not contain the sequence recognized by the northern probe. We used RT-qPCR to determine which of these truncated *tnpA* molecules downregulates a set of functionally related genes (*sicA, sipB* and *sipC*) identified in our RNA-Seq experiment to be repressed by *tnpA*. All three truncated forms of *tnpA* downregulated *sicA, sipB* and *sipC* expression (\>2.5-fold) but not the expression of *thrS*, a gene whose expression was not affected by *tnpA* in the RNA-Seq analysis (Figure [4B](#F4){ref-type="fig"}). From this experiment it is evident that over-expression of only the first 50 nt of *tnpA* is sufficient to negatively regulate expression of the aforementioned genes, indicating that either the 110- or 90-nt processed species is a functional sRNA. It may also be significant that of the three truncated forms of *tnpA* tested in this experiment, *tnpA*~trunc~50 downregulated expression of the target genes to the highest degree and is the only one of the three *tnpA* RNAs incapable of base-pairing with art200 (Figure [4A](#F4){ref-type="fig"}). The latter point may be particularly relevant if art200 factors into *tnpA* transcript processing.

*sicA, sipB* and *sipC* are the first three genes in a large polycistronic transcript encoding secreted effector proteins for the SPI-1 type-III secretion system (T3SS) and are required for invasion of non-phagocytic cells ([@B36]). To gain insight into how *tnpA* regulates *sicAsipBC* we searched for predicted base-pairing interactions between this transcript and the 5΄UTR of *tnpA* using TargetRNA2 ([@B37]) and IntaRNA ([@B38]) but no predicted interactions were found. Transcription of the *sic/sip* operon is activated directly by the SPI-1 encoded transcription factor InvF and the effect of *tnpA* on *sicAsipBC* could therefore be mediated through direct regulation of *invF*. Indeed, all three *tnpA*~trunc~ constructs repressed *invF*, with over-expression of *tnpA*~trunc~−50 reducing *invF* mRNA levels 3.5-fold (Figure [4B](#F4){ref-type="fig"}). We also examined the effect of constitutive over-expression of *tnpA*~trunc~ on InvF protein levels with a strain of SL1344 containing a 3× FLAG tag integrated at the C-terminus of the native *invF* gene. Consistent with our RT-qPCR analysis, *tnpA*~trunc~ repressed InvF protein levels over 2-fold (Figure [4C](#F4){ref-type="fig"}).

We also looked at the ability of *tnpA* to inhibit *invF* expression using over-expressed full-length *tnpA* (*tnpA_7::kan-pTet*, [Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}). We show that in late-exponential phase this strain expressed *tnpA* at a level ∼65-fold higher than the WT strain, and decreased *invF* transcript and protein levels 2--2.5-fold (Figure [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}). For comparison, *invF* levels were decreased 5.7-fold in a *ΔhilA* strain. As HilA is a transcriptional activator of *invF*, the *ΔhilA* strain provides a measure of uninduced *invF* expression. Together, the above data indicates that a *tnpA*-derived sRNA inhibits expression of SPI-1 effector proteins SicA, SipB, SipC by repressing InvF expression.

*Salmonella* Typhimurium employs the SPI-1 T3SS for crossing the intestinal epithelium during the course of an oral infection. Our data thus far shows that *tnpA* over-expression represses expression of components of the SPI-1 T3SS, and we therefore asked if *tnpA* affects invasion of non-phagocytic cells *in vitro*. We infected cultured HeLa cells with WT, *tnpA_7::kan-pTet* or non-invasive (*ΔinvA*) strains of SL1344 to determine if over-expression of full-length *tnpA* alters the rate of invasion. To separate initial invasion from intracellular replication, we used a short time of infection (10 + 30 min recovery) before killing extracellular bacterial cells. As shown in Figure [4F](#F4){ref-type="fig"}, over-expression of *tnpA* reduces invasion 2-fold relative to the WT strain. The agreement between our expression data and invasion experiments led us to conclude that *tnpA* represses SPI-1 mediated invasion of non-phagocytic cells, likely through inhibition of *invF* expression.

Direct interaction between *tnpA* and *invF* {#SEC3-4}
--------------------------------------------

Our work thus far indicated that the *tnpA* mRNA is processed to produce a non-coding RNA (*tnpA*-90 and/or *tnpA*-110) that represses *invF*. As many bacterial ncRNAs act by base-pairing mechanisms, we first used IntaRNA ([@B38]) to find predicted base-pairing interactions between the 5΄end of *tnpA* and *invF*. We identified a single extended region of predicted complementarity between the first 63 nt of *tnpA* and an interval 104--160 nt upstream of the start codon on *invF* (Figure [5A](#F5){ref-type="fig"}). This predicted interaction fits with the above data showing that the first 50 nt of *tnpA* is sufficient for repressing *invF*, and supports *tnpA*-90 or -110 acting as an sRNA. We used a gel shift assay to determine if *tnpA* and the 5΄end of *invF* can base-pair *in vitro*. As the reported transcription start site (+1, TSS) for *invF* is 132-nt upstream of the start codon (in the center of the predicted pairing region) ([@B39]), we elected to start the *in vitro* transcript for *invF* at this position. We observed a modest shift in ^32^P-labeled *invF* upon incubation with increasing concentrations of unlabeled *tnpA* (first 173 nt) (Figure [5B](#F5){ref-type="fig"}, lanes 1--4). Importantly, a complex of the same mobility formed when ^32^P-labeled *tnpA* was incubated with unlabeled *invF* (lanes 5--8). To determine the specificity of *tnpA*:*invF* pairing, we assayed the ability of a previously characterized mutant form of *tnpA* (*tnpA^LS^*, [Supplementary Figure S3C](#sup1){ref-type="supplementary-material"}, ([@B1])) to pair with *invF*; pairing was mostly lost as a consequence of the LS mutations in *tnpA* (lanes 9--11).

![Evidence for a base-pairing interaction between *invF* and *tnpA*. (**A**) Predicted pairing interaction between the first 63 nt of *tnpA* and a region of *invF* 104--160 nt upstream of the start codon. Note that the main transcription start site (TSS, +1) for *invF* is 132 nt upstream of the start codon and nucleotides upstream of the TSS are shown in grey. *invF* nucleotides shown experimentally to be involved in pairing with *tnpA* are indicated in red; *tnpA* LS and T1 mutations are shown in bold. (**B**) Pairing between *tnpA* and *invF* was measured by electrophoretic mobility shift assay. ^32^P-labeled *invF* (−132 to +66 relative to the start codon) or *tnpA* (−103 to +71 relative to the start codon) was incubated with increasing concentrations of unlabeled *tnpA* or *invF* respectively (labeled RNA, 2.4 nM; unlabeled RNA 24, 120, 240 nM) and pairing reactions were analyzed by native PAGE. A mutant form of *tnpA* (*tnpA^LS^*) was also included in this experiment. Certain lanes have been removed from one gel for clarity (vertical white line separating lanes 8 and 9). Reactions containing only the labeled RNA (lanes 1, 5 and 9) are indicated with '−'. (**C**) Pb^2+^ footprinting was used to analyze base-pairing between 5΄^32^P-labaled *invF* (70 nM) and unlabeled *tnpA^WT^* or *tnpA^LS^*(same transcripts as in B). An RNase T1 sequencing reaction (G, lane 1) was used to assign positions of lead sensitivity (numbers relative to the 5΄end), and an untreated RNA control (UT, lane 2) is shown. Red bars to the right of the gel image highlight *tnpA^WT−^-*dependent protections on *invF*. (**D**) RT-qPCR from RNA isolated from the indicated SL1344 strains grown to late-exponential phase (OD~600~ = 1.4). Error bars show standard error on the mean (*n* = 4).](gkx094fig5){#F5}

We next used Pb^2+^ footprinting to define the region on *invF* that base-pairs with *tnpA*. 5^΄32^P-labeled *invF* was incubated with a 5- or 10-fold excess of *tnpA* (WT or LS) before the addition of Pb(II)-acetate. The most substantial region of pairing was a 7-nt interval located 17--23 nt after the *invF* TSS (lanes 3--5, Figure [5A](#F5){ref-type="fig"} and [C](#F5){ref-type="fig"}).

To test if this interaction occurs *in vivo*, we introduced mutations into the *tnpA_7::kan-pTet* construct (T1 mutations, [Supplementary Figure S3C](#sup1){ref-type="supplementary-material"}) that prevent base-pairing with nt 17--23 of *invF* ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). We performed RT-qPCR on RNA extracted from SL1344 WT, *tnpA_7::kan-pTet* and *tnpA_7::kan-pTet-T1* strains grown to late-exponential phase. Over-expression of the WT *tnpA* reduced *invF* and *sicA* levels 3.5- and 2-fold respectively, while the T1 mutant form of *tnpA* did not affect either of these transcripts (Figure [5D](#F5){ref-type="fig"}). Due to the complex transcriptional regulation of *invF* and the location of the pairing region (∼20 nt downstream of the TSS) we have not introduced compensatory mutations to *invF*. This experiment showed that the effect of *tnpA* on SPI-1 expression is sequence specific; combined with our *in vitro* pairing experiments, the above data is consistent with the 5΄ends of *tnpA* and *invF* base-pairing, the consequence of which is reduced *invF* mRNA levels. The ultimate test of this model would be to introduce mutations to *invF* to restore complementarity with the T1 mutant of *tnpA*.

Over-expression of *tnpA* represses expression of SPI-1 in a growth phase dependent manner {#SEC3-5}
------------------------------------------------------------------------------------------

We next asked if the regulation of SPI-1 genes by a *tnpA*-derived sRNA is linked to growth phase, as *invF* expression is induced in late exponential and early stationary phase.

We profiled the expression of *invF* and other SPI-1 encoded genes (*sicA, sipB, sipC* and *prgH*) during five different growth phases in the WT or *tnpA* over-expression (*tnpA_7::kan-pTet)* strains. Importantly, there was no difference in growth rate between the two strains ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}). Over-expression of *tnpA* did not affect SPI-1 gene expression in cells in lag- or early-exponential phase (Figure [6A](#F6){ref-type="fig"} and [B](#F6){ref-type="fig"}). In both of these growth phases, *tnpA* in the WT strain was expressed higher than *invF* (Figure [6F](#F6){ref-type="fig"}), suggesting that the native expression of *tnpA* was sufficient for fully repressing *invF*. Once cells reached late-exponential phase, over-expression of *tnpA* repressed *invF* (2-fold), *sicA* (5.5-fold), *sipB* (4-fold) and *sipC* (2-fold); *prgH* expression (an InvF-independent SPI-1 encoded gene) was not affected by *tnpA* over-expression (Figure [6C](#F6){ref-type="fig"}). At this growth phase *invF* is moderately induced (∼6-fold) relative to early-exponential phase, and is now present at ∼2-fold excess to *tnpA* in the WT strain (Figure [6F](#F6){ref-type="fig"}). Here, endogenous *tnpA* would be limiting, explaining why this growth phase shows the largest impact of *tnpA* over-expression. Lastly, *tnpA* over-expression had a subtle effect on *invF* expression during early- and deep-stationary phase growth, which is likely due to the high expression of *invF* relative to *tnpA* (Figure [6D](#F6){ref-type="fig"}--[F](#F6){ref-type="fig"}).

![Over-expression of *tnpA* RNA downregulates *invF* and *sicAsipBC* in a growth phase dependent manner. RT-qPCR was performed on SL1344 cells (WT or *tnpA_7::kan-pTet*) grown to different growth phases. LB was inoculated with single colonies of the indicated strains and RNA was harvested after 18 h (E, deep-stationary phase). The 18 h cultures were used to seed subcultures and RNA was isolated after 1.25 h (A, lag-phase), 2 h (B, early-exponential phase), 3 h (C, late-exponential phase) or 4 h (D, early-stationary phase). Expression of each gene was normalized to the WT strain grown to early-exponential phase. Error bars show the standard error on the mean (*n* = 4). The relative amount of *tnpA* to *invF* (ΔΔCT) for WT or *tnpA_7::kan-pTet* strains is shown in a heat map (F). Raw ΔCT values (relative to 16S rRNA) for all genes and growth phases are shown in [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}.](gkx094fig6){#F6}

Together, these data show that *tnpA* over-expression affects *invF* levels only when native *tnpA* is expressed at lower levels than *invF*. This suggests the stoichiometry between both transcripts is important, and is consistent with a direct interaction between *tnpA* and *invF*. Additionally, the growth phases where *tnpA* over-expression repressed *sicAsipBC* were the same as those where *tnpA* repressed *invF*, providing additional support to a model where *tnpA* acts through *invF* to repress *sicAsipBC*.

Contribution of native *tnpA* expression to the regulation of SPI-1 expression {#SEC3-6}
------------------------------------------------------------------------------

The observation that over-expressing *tnpA* only affected SPI-1 gene expression in growth phases where native *tnpA* (i.e. in the WT strain) would be limiting relative to *invF* suggested that native IS200 elements play a role in controlling induction of SPI-1. To characterize the regulatory role of native IS200 elements we compared *invF* expression in a strain where four of seven IS200 elements were deleted (*ΔtnpA~2/4/6/7~*) to the WT strain. RNA was isolated from cells grown to early- and late-exponential phase. In both growth conditions, *tnpA* expression was reduced ∼2.5-fold in the Δ*tnpA~2/4/6/7~*strain, and this correlated with a 2-fold increase in *invF* expression in early-exponential phase and a 1.5-fold increase in *invF* expression in late-exponential phase (Figure [7A](#F7){ref-type="fig"}). The smaller effect of reduced *tnpA* expression on *invF* in late-exponential phase is consistent with the above results where *invF* is present at an excess to *tnpA* in this growth phase.

![Contribution of native IS200 elements to regulation of SPI-1 expression. (**A**) RT-qPCR was performed on WT SL1344 and a derivative in which four of seven copies of IS200 were deleted (*ΔtnpA~2/4/6/7~*). RNA was isolated from cells grown to early- or late-exponential phase. Expression of each gene is normalized to the WT strain grown to early-exponential phase. Error bars show the standard error on the mean (*n* = 4). (**B**) Growth of the indicated strains in Lennox Broth (LB) was measured in a 96-well microplate spectrophotometer. Error bars (*n* = 2) are omitted for clarity. Note that the A~600~ was not adjusted for path length and light scattering of the microplate lid and can therefore not be directly compared to OD~600~ measurements of culture density in standard cuvettes. (**C--E**) RNA was isolated from WT SL1344, a derivative where all seven copies of IS200 were deleted (*ΔtnpA*), the *ΔtnpA* strain complemented with over-expression of one copy of *tnpA* (*ΔtnpA/ tnpA_7::kan-pTet)*, and the *ΔtnpA* strain complemented with over-expression of a 5΄truncated *tnpA* (*ΔtnpA/ tnpA_7::kan-pTet(+19)*) grown to early-exponential phase (OD~600~ = 0.5). (C) Primer extension was performed to directly measure *invF* expression. (D) Northern blot analysis to measure *tnpA*, art200 and 5S rRNA levels. PCR products were run on the gel (L) to estimate the size of processed *tnpA* species (indicated with open circles), and the high molecular weight species (closed circle) presumed to be full-length *tnpA*. (E) RT-qPCR was performed to quantitate transcript levels of *invF, sicA, sipC* and *prgH*. Error bars show standard error on the mean (*n* = 3). (**F**) HeLa cells were infected with WT or *ΔtnpA* strains of *Salmonella* Typhimurium SL1344 (MOI of 100) grown to early-exponential phase (OD~600~ ∼ 0.5). A non-invasive strain (Δ*invA*) was also assayed as a control. Bars represent the average invasion for 6 biological replicates (measured in technical duplicate) from two independent experiments. In each experiment, the mean invasion of the WT strain (0.08 and 0.04% of input) was set to 100.](gkx094fig7){#F7}

We then created a full IS200 knockout strain *(ΔtnpA*) where all seven copies were deleted. The *ΔtnpA* strain has a marked growth defect that was suppressed by introducing the *tnpA* over-expression allele into the *ΔtnpA* strain (*ΔtnpA/ tnpA_7::kan-pTet*) (Figure [7B](#F7){ref-type="fig"}). The complementation strain (Δ*tnpA/ tnpA_7::kan-pTet*) expresses *tnpA* at a level much higher than the WT strain (Figure [7D](#F7){ref-type="fig"}) which suggests that a relatively low amount of *tnpA* is required for maximal growth. The growth defect in the Δ*tnpA* strain provides direct evidence that native IS200 elements contribute to host fitness in *S*. Typhimurium. We next measured *invF* expression in WT, *ΔtnpA* and *ΔtnpA/ tnpA_7::kan-pTet* strains grown to early-exponential phase (OD~600~ = 0.5). At this growth phase *invF* was barely detectable by primer extension in the WT strain, but increased dramatically in the strain without IS200 elements (Figure [7C](#F7){ref-type="fig"}). Importantly, *invF* expression was reduced to close to WT levels in the complementation strain. Unexpectedly, a second strain encoding *tnpA* starting at nt 19 (*tnpA_7::kan-pTet(+19)*) also suppressed *invF* expression. This could be an indication that residues in *tnpA* downstream of the 'expected' seed region (see data in Figure [5](#F5){ref-type="fig"}) play an important role in *invF* pairing.

To quantitate the effect of native *tnpA* expression on SPI-1 gene expression we performed RT-qPCR on the RNA used in Figure [7C](#F7){ref-type="fig"} and [D](#F7){ref-type="fig"} to measure *invF, sicA, sipC* and *prgH* expression. Transcript levels of all four genes increased 20- to 25-fold in the *ΔtnpA* strain and complementation with both of the *tnpA_7::kan-pTet* complementation alleles reduced expression close to WT levels (Figure [7E](#F7){ref-type="fig"}). Surprisingly, *prgH* expression was also upregulated in the *ΔtnpA* strain. As PrgH, a component of the T3SS needle complex, is not regulated by *invF*, this unexpected result could be indicative of *tnpA* also affecting the expression of a gene upstream of *invF* in the SPI-1 expression cascade. Lastly, we measured the impact of deleting IS200 elements on the rate of invasion into cultured HeLa cells. Consistent with our expression data, the *ΔtnpA* strain was 6.7-fold more invasive than the WT strain (Figure [7F](#F7){ref-type="fig"}).

Overall, the finding that over-expressing and deleting *tnpA* have opposing effects on *invF, sicA* and *sipC* gene expression and *Salmonella* invasion strongly supports the conclusion that *tnpA* plays an important role in regulating SPI-1 functions.

DISCUSSION {#SEC4}
==========

In the current work we asked if IS200 encoded transcripts affect gene expression in *S*. Typhimurium. IS200 is an unusual transposon in that it is often present in high copy number in many *Salmonella* and *Yersinia* spp. but the transposon itself is almost completely dormant. The low transposition frequency of IS200 can be explained by close to no synthesis of the TnpA protein ([@B1]). However, the IS200 transposase mRNA (*tnpA*) is expressed at a moderate level in *S*. Typhimurium, resulting in a paradox where this transposon has evolved to maintain transcription of the transposase mRNA but essentially no translation of the protein. Here we provide an explanation for this paradox by demonstrating that over-expression of *tnpA* alters the expression of at least 73 genes in *S*. Typhimurium, including many genes involved in pathogenesis. We provide evidence that *tnpA* is processed to produce small regulatory RNAs that inhibit expression of the SPI-1 encoded transcription factor *invF* by a base-pairing mechanism and this impacts on the ability of *Salmonella* to invade HeLa cells *in vitro*.

Ribonucleolytic processing of *tnpA* mRNA generates sRNA regulators of *invF* expression {#SEC4-1}
----------------------------------------------------------------------------------------

We began the current study by profiling the effect of *tnpA* over-expression on gene expression in *S*. Typhimurium. In this experiment we observed strong repression (\>2-fold) of 73 genes, 8 of which (*sipC, sipA, sseA, sseL, sigE, sopB, sicA, sipB*) are involved in pathogenesis. Although *tnpA* over-expression also represses art200 expression, four of these virulence genes (*sicA, sipB, sipC* and *sopB*) were repressed by a *tnpA* mutant that is unable to downregulate art200. As *tnpA* is almost never translated, we speculated that all or part of *tnpA* may act as a non-coding RNA to regulate gene expression in *S*. Typhimurium.

It is now clear that untranslated regions of mRNAs serve as a rich reservoir of sRNAs. As we had observed an effect from over-expressing the 5΄portion of *tnpA*, we asked if IS200 expresses a 5΄UTR derived sRNA. The typical 5΄UTR derived sRNA (5΄sRNA) is transcribed from the same promoter as an mRNA and transcription terminates at an intrinsic terminator upstream of the coding sequence for the mRNA ([@B12],[@B40],[@B41]). Although most 5΄sRNAs terminate at an intrinsic terminator, post-transcriptional processing occurs for several previously described 5΄sRNAs ([@B41]--[@B43]). Indeed, our primer extension and northern analysis revealed that the 5΄end of *tnpA* contains two processing sites which produce ∼110-nt RNA initiating at the *tnpA* transcription start site and ending at nt ∼108 (*tnpA*-110) and ∼90-nt species (*tnpA*-90) that is likely generated by processing at nt 19 of *tnpA*-110. Similar to Type II 3΄UTR derived sRNAs, the *tnpA* sRNAs are likely stable processing intermediates of *tnpA*, whereby the biogenesis of the *tnpA* sRNAs comes as a consequence of ribonucleolytic degradation of an mRNA ([@B35]). Evidence for the instability of *tnpA* 3΄ of processing sites comes from the relatively small amount of these downstream products detected by primer extension. At this point we have not identified the ribonuclease responsible for ribonucleolytic processing of *tnpA* but we predict that RNase III and/or RNase E would be involved based on sequence and structural elements at both processing sites. Future work will investigate the precise mechanism of endoribonucleolytic processing of *tnpA* including the potential involvement of art200 in generating *tnpA*-110 and -90.

We found that only the first 50 nt of *tnpA* is required for repressing *invF* and *sicAsipBC* expression which fits fully with *tnpA*-110 and/or -90 acting as a trans-acting sRNA. Mutations to nt 12--19 of *tnpA* (*tnpA*^T1^) prevent pairing with *invF in vitro* and repression of *invF in vivo*, consistent with the first 19 nt containing base-pairing residues. However, as a construct lacking the first 19 nt of *tnpA* retained the capacity to repress *invF* expression, it is likely that residues downstream of nt 19 also contribute significantly to *invF* pairing. Consistent with this is the observation that the *tnpA*^LS^ mutant impaired *tnpA*--*invF* pairing *in vitro* (Figure [5](#F5){ref-type="fig"}).

While we do not yet know how *tnpA--invF* pairing represses *invF* expression we speculate that pairing primarily leads to degradation of *invF* mRNA. The putative *tnpA--invF* interaction occurs at the extreme 5΄end of *invF*, ∼110 nt upstream of the translation start codon (Figure [5](#F5){ref-type="fig"}). Base-pairing might recruit RNases to actively degrade *invF* mRNA ([@B44]). This model is particularly appealing for *tnpA*-90, as the 5΄monophosphate on this RNA species could directly stimulate RNase E cleavage ([@B45]). However, the *tnpA* complementation allele initiating at nt 19 (*tnpA_7::kan-pTet(+19)*) would have a 5΄ triphosphate and this strain repressed SPI-1 expression to almost the same extent as the full-length *tnpA* (Figure [7E](#F7){ref-type="fig"}). Alternatively, either *tnpA*-90 or -110 may interfere with translation. sRNAs can interfere with translation initiation by base-pairing 50--100 nt upstream of the translation start codon ([@B46]--[@B49]). The fact that *tnpA* inhibited InvF protein expression at an early growth phase (Figure [4E](#F4){ref-type="fig"}) while not affecting *invF* mRNA levels (Figure [6E](#F6){ref-type="fig"}) suggests that translation inhibition is at least one consequence of *tnpA--invF* pairing. More work is required to determine the molecular mechanism(s) for how *tnpA* inhibits *invF* expression.

While the current work presents the first example of a bacterial transposon producing trans-acting sRNAs, there are two recent examples of transposase derived sRNAs in archaea. The *Sulfolobus solfataricus* sRNA RNA-257 shares substantial homology with the 3΄UTR of the ISC1904 transposase, ORF1182. RNA-257 is believed to be a remnant of transposition reactions, and this sRNA base-pairs with ORF1183, which encodes a putative phosphate transporter. Similar to *tnpA--invF*, base pairing between RNA-257 and ORF1183 results in degradation of the mRNA ([@B8]). In *Halobacterium salinarum*, the IS1341 transposase, *tnpB*, expresses more than 10 different sRNAs, one of which regulates growth rate by an undetermined mechanism ([@B9]). Notably, our observation that deletion of all of the IS200 copies in *S*. Typhimurium impacted on the expression of an SPI-1 gene (*prgH*) not under the control of InvF is consistent with *tnpA* producing either a multi-functional regulatory RNA or, as in the case of IS1341, multiple regulatory sRNAs. Additional studies on the processing of *tnpA* will be required to further address these possibilities.

It is perhaps surprising that neither *tnpA*-110 or -90 have been detected in previous work identifying sRNAs in *S*. Typhimurium ([@B14],[@B24],[@B39]). However, a standard practice in mapping RNA-Seq reads to the reference genome is to omit non-unique reads, and the presence of seven identical copies of IS200 in SL1344 would result in reads derived from *tnpA* being overlooked. However, we note that *tnpA* is enriched up to 4.1-fold in Hfq-CoIP experiments ([@B14]), and the previously characterized Hfq-binding site on *tnpA* (nt 68--83; ([@B1])) would be present in both *tnpA*-110 and -90. We have not yet investigated the role of Hfq in *tnpA--invF* pairing, in part due to the complications of dysregulated SPI-1 expression (destabilized *hilD*) ([@B50]) in an *hfq*-null strain.

Regulatory cross-talk between horizontally acquired genes and the *S*. Typhimurium core genome {#SEC4-2}
----------------------------------------------------------------------------------------------

*Salmonella* Typhimurium contains a mosaic genome consisting of a core genome complemented with a number of horizontally acquired genetic elements. The core genome is highly conserved among Enterobacteriaceae and contains all of the genes required for normal cellular processes. The accessory or 'flexible' genome is made up of a number of horizontally acquired genes including pathogenicity islands, prophage, plasmids and transposons. This flexible genome has been acquired over evolutionary time and provides most of the genes required for virulence ([@B51]). Horizontally acquired genes become integrated into host regulatory networks whereby components of the core genome regulate horizontally acquired genes and the core genome itself can be regulated by members of the accessory genome ([@B52]). In *S*. Typhimurium, the core genome encoded sRNA SgrS represses expression of the SPI-1 effector *sopD* ([@B53]), while the SPI-1 encoded sRNA InvR represses expression of the core genome encoded *ompD* ([@B54]). In enterohaemorrhagic *E. coli*, a bacteriophage encoded sRNA, AgvB, represses the core genome encoded sRNA GcvB, thereby increasing expression of many genes involved in amino acid transport ([@B55]). In the current work we provide evidence of cross-talk between members of the accessory genome, where a transposon derived sRNA controls expression of part of the SPI-1 T3SS by repressing expression of *invF*.

Activation of SPI-1 is controlled by a complex network of transcriptional, post-transcriptional and post-translational regulation ([@B56],[@B57]). Environmental signals including low oxygen and high osmolarity first converge to activate transcription of *hilD*. HilD, HilC and RtsA then participate in a feed-forward loop that converges on activation of *hilA*, which in turn activates transcription of structural components of the needle complex (*prg/org*) as well as *invF*, which is a transcriptional activator of secreted effector proteins (sic/sip and others) (Figure [8](#F8){ref-type="fig"}). In the current work we have identified a new component of this complex regulation: processed forms of *tnpA* repress *invF* expression in a growth phase dependent manner. We propose that similar to recently identified sRNA 'sponges' ([@B55],[@B58]--[@B60]), *tnpA* sets a threshold for activation of *invF*.

![Model for role of *tnpA* in regulating SPI-1 gene expression. Environmental signals activate transcription of *hilD*, which activates a feed-forward loop that converges on activation of *hilA*. HilA is a transcriptional activator of components of the needle complex (*prg/org*) as well as *invF*, a transcriptional activator of SPI-1 effector proteins (sic/sip and other genes). Processed forms of *tnpA* (*tnpA-110* and *-90*) base-pair with *invF* mRNA and inhibit *InvF* expression. Three activation checkpoints for SPI-1 gene expression are indicated with dashed boxes.](gkx094fig8){#F8}

Expression of virulence genes has an extreme fitness cost for many bacteria including *S*. Typhimurium, *Y. pestis* and *Shigella flexneri* ([@B61]--[@B63]). For example, single cell analyses revealed that SPI-1 induction dramatically retarded growth and this growth defect was abrogated by deleting the *sic/sip* locus ([@B63]). In addition, we have shown here that over-expression of *invF, sicA* and *sipC* correlates with a reduced growth rate for *S*. Typhimurium in rich media. As the *sicA* promoter has the longest relaxation time for SPI-1 encoded genes ([@B64]), induction of *sic/sip* by InvF represents a key commitment step to virulence and the associated burden of producing effector proteins. We propose a model where repression of *invF* by *tnpA* sets a threshold for *invF* induction that must be passed to induce expression of virulence factors (Figure [8](#F8){ref-type="fig"}). Evidence for this comes from two key experiments. First, when we profiled SPI-1 expression over growth we noted that (i) *tnpA* was expressed higher than *invF* in lag and early-exponential phase, and (ii) over-expression of *tnpA* did not affect *invF* expression in these two growth phases (Figure [6](#F6){ref-type="fig"}). Second, reducing *tnpA* expression 2-fold in early-exponential phase increased *invF* expression \>2-fold, while the same reduction in *tnpA* expression in late-exponential phase resulted in only a 1.4-fold increase in *invF* (Figure [7](#F7){ref-type="fig"}). This threshold for activation would ensure that InvF is only synthesized once there is a sufficiently high transcriptional activation of the *invF* promoter by HilA. A similar threshold for activation occurs for activation of both *hilD* and *hilA* ([@B64],[@B65]). In the case of *hilD*, post-translational repression by HilE dampens *hilD* activation, and H-NS repression of *hilA* counteracts transcriptional activation by HilD, HilC and RtsA ([@B66]). An additional role of *tnpA* may be to prevent leaky expression of *invF*, particularly HilC-dependent activation of the alternative promoter for *invF* (p*~invF~-2*, Figure [8](#F8){ref-type="fig"}) ([@B67],[@B68]). While *hilD, rtsA* and *hilA* are strongly repressed prior to induction, *hilC* is expressed at a basal level and expression has minor fluctuations independent of *hilD* ([@B63]). As the predicted *tnpA--invF* base-pairing interaction extends 30 nt upstream of the HilA-dependent TSS for *invF*, the HilC-dependent *invF* transcript may be subject to even stronger repression by *tnpA*.

Our model predicts that the absence of IS200 elements would lead to premature activation of SPI-1. In a WT strain, *invF* is induced 6-fold in late-exponential phase and 60-fold in early-stationary phase, when compared to early-exponential phase (Figure [6](#F6){ref-type="fig"}). In the absence of IS200 elements, *invF* is induced 25-fold in early-exponential phase when compared to the WT strain (Figure [7E](#F7){ref-type="fig"}). The early activation of *invF* expression in the *ΔtnpA* strain correlates with a 6.7-fold increase in invasion, as well as substantially reduced growth rate (Figure [7](#F7){ref-type="fig"}). Together, these experiments provide evidence that IS200-encoded RNAs play an important role in delaying the activation of the SPI-1 T3SS and that this delayed activation provides a selective growth advantage to *S*. Typhimurium.

Bacterial transposons as a source of regulatory RNA {#SEC4-3}
---------------------------------------------------

Our initial goal for the current work was to determine if any IS200 encoded RNAs affect gene expression in *S*. Typhimurium. Our transcriptomics experiment identified at least 73 genes that are dysregulated by *tnpA* over-expression. We have investigated how *tnpA* impacts on expression of three of these genes (*sicA, sipB* and *sipC*) and our data is consistent with an indirect mechanism where *tnpA* acts through *invF* to control *sicAsipBC* expression. We believe that the effect of *tnpA* on many of the other genes identified here will likewise be indirect, and mediated through a smaller number of direct targets. Regardless of the mechanism by which *tnpA* regulates gene expression in *S*. Typhimurium, we have identified a new way that bacterial transposons can ensure survival: contributing a regulatory RNA. The dual use of a promoter for mRNA and sRNA would ensure that transcription of the transposase is maintained, and post-transcriptional regulation of TnpA expression protects against detrimental effects of transposition.

It is now clear that bacterial sRNAs can be derived from unexpected places. Transposons likely represent an unexplored reservoir of regulatory RNAs that could ultimately provide a benefit to the host organism.
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